Cargando…
Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
The value of adjuvant chemotherapy in elderly patients has been the subject of many overviews, with opinions varying from “not effective”, since randomized trials have not been performed, to “as effective as in young individuals”, based upon many retrospective analyses of randomized trials that have...
Autores principales: | Glimelius, Bengt, Osterman, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464071/ https://www.ncbi.nlm.nih.gov/pubmed/32823998 http://dx.doi.org/10.3390/cancers12082289 |
Ejemplares similares
-
Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It?
por: Osterman, Erik, et al.
Publicado: (2020) -
ASO Author Reflections: Emerging Risk Factors in Colon Cancer—End of the Line for Clinomics?
por: Osterman, Erik, et al.
Publicado: (2019) -
A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer
por: Lindskog, Elinor Bexe, et al.
Publicado: (2014) -
Adjuvant chemotherapy
por: Glimelius, B.
Publicado: (2013) -
Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2019)